California Proposition 38
A statute authorizing $8.4 billion in bonds for immunology and immunotherapy research aimed at diseases like cancer, heart disease, and Alzheimer’s. Half the funding goes to a single University of California-affiliated nonprofit research institute; the other half is distributed as research grants. Drugs resulting from the research must be discounted 20% for Californians, and 10% of related revenue would go to the state general fund.
A “yes” vote would authorize this bond.
A “no” vote would not.
What would it cost?
Increased state costs of $500 million to $600 million annually for about 20 years, potentially offset if the funded research generates revenue.Support
Supporters include: California Democratic Party, American Association of Immunologists, Michael J. Fox Foundation, Alzheimer’s Los Angeles, City of Hope.Supporters argue the research could produce breakthroughs on major diseases, especially given federal cuts to health science funding.Opposition
Opponents include: League of Women Voters, California Health Policy Strategies, Robert Kaplan (Stanford University School of Medicine).Opponents question why half the money goes to a single nonprofit without open competition, note that California’s past biomedical bonds haven’t delivered promised royalty revenue, and argue research funding should go through the normal state budget process rather than a ballot measure and decades of new bond debt.